Lyme Literate Doctors and the Challenge of Individualized Care

Debate over “Lyme-literate doctors” often centers on treatment decisions in complex cases. A 2016 JAMA article highlighted concerns about prolonged antibiotic therapy following a reported adverse drug reaction. :contentReference[oaicite:0]{index=0}

The Case: DRESS Syndrome After Treatment

The case involved a 45-year-old woman treated for Lyme disease and Babesia who developed drug reaction with eosinophilia and systemic symptoms (DRESS), a rare but recognized complication of antibiotic therapy.

She had a history of persistent neurologic and gastrointestinal symptoms and had sought multiple medical opinions prior to treatment.

How the Case Was Interpreted

The authors questioned the approach of the treating physician, describing the use of longer-term antibiotics as outside standard practice.

However, the discussion did not fully address the diagnostic uncertainty that can arise in patients with overlapping symptoms and incomplete laboratory confirmation.

Diagnostic Challenges in Lyme Disease

Accurate diagnosis of Lyme disease and coinfections remains difficult.

Early testing may lack sensitivity, and laboratory results can vary depending on timing and methodology. Studies have shown that standard two-tier testing may miss a proportion of early cases.

In this context, clinicians may rely on clinical judgment in addition to laboratory findings.

Balancing Treatment Risks and Benefits

All medical treatments carry risk, including antibiotics.

At the same time, undertreatment of tick-borne illness may also have consequences, particularly when symptoms persist or evolve.

Published studies have documented that some patients continue to experience symptoms following standard treatment, highlighting the complexity of care decisions.

Differences in Treatment Approaches

Guidelines vary in their recommendations.

Some support shorter courses of therapy, while others allow for individualized approaches based on clinical presentation and response to treatment.

These differences reflect ongoing uncertainty rather than a single universally accepted approach.

Interpreting the Evidence

The JAMA authors recommended non-antibiotic approaches such as cognitive behavioral therapy and supportive care.

While these strategies may be appropriate in selected cases, the evidence base remains limited and may not apply to all patients—particularly those with ongoing or complex symptoms.

Clinical Perspective

Cases such as this highlight the challenges of managing patients with persistent or atypical symptoms.

Individualized care—guided by clinical judgment, patient history, and evolving evidence—remains an important part of practice in complex conditions.

Rather than focusing solely on treatment duration, it may be helpful to consider the broader clinical picture, including diagnostic uncertainty, potential co-infections, and variability in patient response.

Patients may benefit from understanding coinfections, reviewing testing limitations, and exploring persistent symptoms when care decisions are unclear.

References

1. Marks CM et al. Antibiotic Treatment for Chronic Lyme Disease—Say No to the DRESS. JAMA Intern Med. 2016.
2. Molins CR et al. Clin Infect Dis. 2015.
3. Aucott JN et al. Clin Vaccine Immunol. 2016.
4. Logigian EL et al. N Engl J Med. 1990.
5. Fallon BA et al. Neurology. 2008.
6. Cameron DJ et al. Expert Rev Anti Infect Ther. 2014.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention